Zobrazeno 1 - 10
of 167
pro vyhledávání: '"R Kristeleit"'
Autor:
A. Samani, R. Bennett, K. Eremeishvili, F. Kalofonou, S. Whear, A. Montes, R. Kristeleit, J. Krell, I. McNeish, S. Ghosh, L. Tookman
Publikováno v:
ESMO Open. 8:100640
Autor:
J.A. Lopez-Vilariño, Eva Guerra, Victor Moreno, Emiliano Calvo, Vicente Alfaro, R Kristeleit, Mariano Siguero, Neus Basté, Martin Forster, Valentina Boni, Ali Zeaiter, Ignacio A. Romero, Carmen Kahatt
Publikováno v:
International Journal of Gynecological Cancer
ObjectiveSecond-line treatment of endometrial cancer is an unmet medical need. We conducted a phase I study evaluating lurbinectedin and doxorubicin intravenously every 3 weeks in patients with solid tumors. The aim of this study was to characterise
Autor:
Keiichi Fujiwara, Robert L. Coleman, Amit M. Oza, Lara Maloney, Frederik Marmé, Bradley J. Monk, Ramez N. Eskander, R Kristeleit, Tamar Safra, Kevin K. Lin, David M. O'Malley, Shannon N. Westin, Nikolay Grechko, Ana Oaknin, Domenica Lorusso, Michelle K. Wilson, Thomas J. Herzog, Danny Shih, Stephanie Hume, Sandra Goble, Iain A. McNeish
Publikováno v:
International Journal of Gynecological Cancer
BackgroundThe optimal treatment strategy for women with newly diagnosed ovarian cancer has yet to be determined. Poly(ADP-ribose) polymerase (PARP) inhibitors have demonstrated substantial improvement in progression-free survival as monotherapy maint
Autor:
K. Fujiwara, R. Kristeleit, S. Ghamande, M-C. Lim, C. Parkinson, M. Morgan, M.K. Wilson, A. Oaknin, J. Buscema, P. Bessette, D. Lorusso, F. Ueland, T. Safra, J.N. Barlin, F. Marmé, T.J. Herzog, I.A. McNeish, S. Goble, S. Hume, B.J. Monk
Publikováno v:
Annals of Oncology. 33:S1505-S1506
Autor:
R. Kristeleit, S. Ghamande, M-C. Lim, C. Parkinson, M. Morgan, M. Wilson, A. Oaknin, J. Buscema, P. Bessette, D. Lorusso, F. Ueland, T. Safra, J. Barlin, F. Marmé, T.J. Herzog, I. McNeish, S. Goble, S. Hume, K. Fujiwara, B.J. Monk
Publikováno v:
Annals of Oncology. 33:S786-S787
Autor:
Nina L. Jebsen, Brynjar Mauseth, Ketil André Camilio, Ahmad Awada, George Lazaridis, Christiane Jungels, Hamina Patel, Aurélien Marabelle, Vibeke Sundvold, Fabienne Hermitte, Delphine Loirat, James Spicer, Øystein Rekdal, Berit Nicolaisen, R Kristeleit, Paal Brunsvig, Andrew Saunders, Dag Erik Jøssang, Jérôme Galon, Baldur Sveinbjørnsson, Jean Francois Baurain
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. xx, no.xx, p. xx (2021)
Purpose: LTX-315 is a first-in-class, 9-mer membranolytic peptide that has shown potent immunomodulatory properties in preclinical models. We conducted a phase I dose-escalating study of intratumoral LTX-315 administration in patients with advanced s
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
I. Vergote, A. González-Martín, I. Ray-Coquard, P. Harter, N. Colombo, P. Pujol, D. Lorusso, M.R. Mirza, B. Brasiuniene, R. Madry, J.D. Brenton, M.G.E.M. Ausems, R. Büttner, D. Lambrechts, M. Ausems, J. Brenton, M. Abreu, S. Balboni, S. Banerjee, M. Barberis, M.P. Barretina Ginesta, J.-F. Baurain, M. Bignami, L. Bjorge, P. Blecharz, I. Bruchim, M. Capilna, N. Cerana, A. Cicchetti, D. Collins, N. Concin, M. D’Incalci, B. Davidson, T. de la Motte Rouge, P. De Iaco, F. Demirkiran, H. Denys, T. Doerk, A. Dorum, A. Ferrero, A.P. Fidalgo, M. Genuardi, L. Gladieff, R. Glasspool, C. Grimm, M. Gultekin, E. Hahnen, A. Hasenburg, A. Hegmane, V. Heinzelmann, E. Hogdall, R. Janavicius, S. Jarmalaite, R. Kalachand, R. Kaneva, S. Kilickap, R. Kocian, D. Kolencik, R. Kristeleit, A. Kryzhanivska, A. Leary, B. Lemley, M. Ligtenberg, J.A. López-Guerrero, C.J. Lord, E. Avall-Lundqvist, J. Maenpaa, S. Mahner, F. Marmé, C. Marth, I. McNeish, S. Merkelbach-Bruse, M. Mourits, N. Normanno, A. Oaknin, K. Ojamaa, C. Papdimitriou, F. Penault-Llorca, A.M. Perrone, S. Pignata, E. Pikarsky, E. Rouleau, M. Rubio, A. Sapino, B. Schmalfeldt, J. Sehouli, R. Shapira, K.D. Steffensen, V. Sukhin, J. Syrios, Z. Szallasi, C. Taskiran, M. Terzic, M. Tischkowitz, I. Toth, K. Van de Vijver, M.A. Vardar, B. Wasag, P. Wimberger, E. Witteveen
Publikováno v:
Annals of Oncology, 33, 3, pp. 276-87
Vergote, I, González-Martín, A, Ray-Coquard, I, Harter, P, Colombo, N, Pujol, P, Lorusso, D, Mirza, M R, Brasiuniene, B, Madry, R, Brenton, J D, Ausems, M G E M, Büttner, R, Lambrechts, D, European experts’ consensus group & Dahl Steffensen, K 2022, ' European experts consensus : BRCA/homologous recombination deficiency testing in first-line ovarian cancer ', Annals of Oncology, vol. 33, no. 3, pp. 276-287 . https://doi.org/10.1016/j.annonc.2021.11.013
ANNALS OF ONCOLOGY
Annals of Oncology, 33, 276-87
Vergote, I, González-Martín, A, Ray-Coquard, I, Harter, P, Colombo, N, Pujol, P, Lorusso, D, Mirza, M R, Brasiuniene, B, Madry, R, Brenton, J D, Ausems, M G E M, Büttner, R, Lambrechts, D, European experts’ consensus group & Dahl Steffensen, K 2022, ' European experts consensus : BRCA/homologous recombination deficiency testing in first-line ovarian cancer ', Annals of Oncology, vol. 33, no. 3, pp. 276-287 . https://doi.org/10.1016/j.annonc.2021.11.013
ANNALS OF ONCOLOGY
Annals of Oncology, 33, 276-87
BACKGROUND: Homologous recombination repair (HRR) enables fault-free repair of double-stranded DNA breaks. HRR deficiency is predicted to occur in around half of high-grade serous ovarian carcinomas. Ovarian cancers harbouring HRR deficiency typicall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::048b3ea84583ffb10df0f113446b4777
Autor:
Jubilee Brown, Ellie Im, R Kristeleit, L Duska, L Gilbert, A Tinker, A Oaknin, J Veneris, J Press, DM O'Malley, Charles A. Leath, Renaud Sabatier, V Samouëlian, V Boni, Prafull Ghatage, S Ghamande, B Pothuri, T Duan, C Mathews
Publikováno v:
Oral Abstracts.
Autor:
Francesco Raspagliesi, Giovanni Scambia, Marina Nechaeva, Yaroslav Shparyk, Igor Bondarenko, Róbert Póka, R Kristeleit, Tamar Safra, Nicoletta Colombo, Alla Sergeevna Lisyanskaya, Ana Oaknin, L Biela, David Cibula, A. Fedenko, Valentyn Svintsitskiy, A.C. de Melo, Mikhail Dvorkin, Beata Mackowiak-Matejczyk, Ling Ma, Irina Rakhmatullina
Publikováno v:
Oral Abstracts.